Xtent IPO Raises $75.2 Million

Xtent Inc., a Menlo Park, Calif.-based developer of stent systems, prices 4.7 million common shares at $16 per share ($16-$18 range), for an IPO take of approximately $75.2 million. It will  trade on the Nasdaq under ticker symbol XTNT, while Piper Jaffray served as lead underwriter. Xtent has raised around $75 million in total VC funding since its 2002 inception, including a $30 million Series D round last year at a post-money valuation of around $160 million. Backers include Morgenthaler Partners, Advanced Technology Ventures, Latterell Venture Partners and St. Paul Venture Capital. www.xtentinc.com< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />